Business ❯ Startups

Biotechnology

Funding Drug Development Genetics Clinical Trials Genetic Engineering Pharmaceuticals Cancer Treatment ThermoReLeaf SAS Employment Cryonics Services Sustainable Food Sinopia Biosciences Patent Protection Longevity Medicine Investment Health Innovations Protein Design Pharmaceutical Startups Commercialization Cancer Research Medical Devices Prenetics Genetic Research Theranos Defense-Biotech Drug Licensing Preventive Technologies Drug Discovery Consumer Genetics Research Funding Colossal Agricultural Technology Health Technology Fraud Employee Relations Funding Initiatives Anti-aging Longevity De-extinction Sustainable Solutions Venture Capital Probiotics Longevity Biotech Gene Therapy Genetic Testing Medical Technology Cryonics Companies

Sinopia’s SB-0110 Boosts Levodopa Benefit and Cuts Dyskinesia in Animal Models

Peer‑reviewed preclinical results show a trapidil‑derived compound preserved levodopa’s motor programs, lowered involuntary movements, prompting Sinopia to complete toxicology before planned first‑in‑human trials next year.

NewLimit Raises $435 Million to Advance First Human Trial for Liver Rejuvenation

UAE Backs Colossal’s BioVault at Dubai Museum to Bank Genetic Material From Imperiled Species

Chai Discovery Raises $130 Million Series B at $1.3 Billion Valuation

AI Pinpoints Target of New IBD Antibiotic Enterololin, Speeding Development